글로벌 방광 외반증 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 방광 외반증 시장

방광 외반증 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간 동안 시장이 6.90%의 CAGR로 성장할 것으로 분석합니다.

방광 외반증은 드물고 복잡한 선천적 결함으로, 방광 외반증이라고도 알려져 있습니다. 이 질환은 방광 과 골반 뼈가 비정상적으로 형성되는 것이 특징입니다. 방광은 납작해지고 태아 외부에서 발달하며 골반 뼈도 넓게 분리됩니다. 방광 외반증은 요로, 골반 골격 근육과 뼈, 생식 기관 및 장관을 포함한 신체 내 여러 시스템을 포함합니다. 이 결함의 증상은 상방요도, 소변 역류, 음경 조음, 작은 방광, 치골 분리, 척추 지방종, 신장 문제 및 장 문제입니다.

질병 유병률 증가, 의료비 지출 증가, 치료 옵션 개발, 정부 자금 지원 증가, 희귀 질병에 대한 인식을 확산하기 위한 정부 및 민간 기관의 이니셔티브 증가는 방광 외반증 시장을 확대할 요인입니다. 연구 개발 활동의 증가와 신흥 시장은 2021-2028년 예측 기간 동안 방광 외반증 시장에 유익한 기회를 제공할 것입니다.

그러나 치료 비용이 높고 희귀 질환에 대한 인식이 부족하며 불임, 요실금, 압출된 방광에서 악성 종양이 증가하고 급성 신우염이 발생하는 등 치료와 관련된 합병증이 시장 성장을 방해하는 요인이며, 앞서 언급한 예측 기간 동안 방광 외반증 시장에 더욱 어려움을 겪을 것입니다.

This bladder exstrophy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bladder exstrophy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Bladder Exstrophy Market Scope and Market Size

The bladder exstrophy market is segmented on the basis of treatment, diagnosis, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the bladder exstrophy market is segmented into surgery, osteotomy, analgesics, antibiotic and others. Surgery has been further sub-segmented into complete repair and staged repair.
• On the basis of diagnosis, the bladder exstrophy market is segmented into blood tests, urine tests, MRI, X-ray, ultrasound and others.
• On the basis of end-users, the bladder exstrophy market is segmented into clinic, hospital and others.

The bladder exstrophy market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Bladder Exstrophy Market Country Level Analysis

Bladder exstrophy market is analyzed and market size information is provided by the country, treatment, diagnosis, end-users and distribution channel as referenced above.

The countries covered in the bladder exstrophy market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the bladder exstrophy market due to the presence of major key players, growing investment for R&D activities, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Bladder exstrophy market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Bladder Exstrophy Market Share Analysis

Bladder exstrophy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to bladder exstrophy market research.

방광 외반증 시장 보고서에 포함된 주요 기업으로는 Allergan, Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Melinta Therapeutics LLC, Basilea Pharmaceutica Ltd., Tetraphase Pharmaceuticals, Paratek Pharmaceuticals, Inc., Nabriva Therapeutics plc, Spero Therapeutics, Abbott, F. Hoffmann-La Roche Ltd., Mylan NV, Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Lilly, Aurobindo Pharma, Lupin, SHIONOGI & Co., Ltd., AbbVie Inc., Cipla Inc., AstraZeneca, Johnson & Johnson Private Limited 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-66332